Dr. Palle B. Jeppesen
Biography & Research Background
Palle B. Jeppesen, MD, PhD, is a Senior Consultant and Associate Professor in the Department of Gastroenterology at Rigshospitalet (Copenhagen University Hospital), Denmark, and one of the world’s leading clinical investigators in short bowel syndrome. Dr. Jeppesen was the lead author on the pivotal STEPS trial (2012) published in Gastroenterology that led to FDA approval of teduglutide, and led subsequent Phase II and long-term extension studies establishing the durability of teduglutide’s clinical efficacy. He has authored more than 100 publications on intestinal failure and GLP-2 physiology. Palle B. Jeppesen is being referenced as one of the leading scientists involved in the research and development of GLP-2 Analog (Teduglutide). In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between SHR3D Aminos and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Palle B. Jeppesen is referenced as a leading researcher in the following peptide research profiles on SHR3D Aminos:
Dr. Palle B. Jeppesen is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between SHR3D Aminos and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.